Ep

Epilepsia

Epilepsia is a journal published on behalf of the International League Against Epilepsy that covers innovative clinical and basic science research on all aspects of epilepsy and seizures. It also publishes critical reviews, opinion pieces, and guidelines intended to improve understanding, diagnosis, and treatment.

Looking to publish in Epilepsia? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Clinical Neurology
Impact Factor 6.6
Quartile Q1
Open Access Type Hybrid
ISSN 0013-9580
eISSN 1528-1167
Invitation Only No
Cost Range Open Access APC: $4,580 USD / £3,070 GBP / €3,820 EUR, plus applicable taxes.

Submission Instructions

Epilepsia accepts the following article types. Click on an article type to view submission instructions.

Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 300 words. Abstract must be structured.
Manuscript Manuscript must not exceed 4,000 words. Manuscript must contain the sections abstract, introduction, methods, results, and conclusions. Manuscript must include 3 to 5 key bullet points summarizing the article and up to 5 keywords or phrases.
References References must not exceed 50. References may be submitted in any citation style or format if used consistently throughout the manuscript. References may be formatted in any consistent style or format.
Figures & Tables Figures and tables must not exceed 6 combined. Figures must be uploaded as separate files, and tables must be presented together at the end of the main text document or submitted as separate table files rather than embedded in the main text. Figures and tables must have legends, and each table must include a title and footnotes.
Reformat to Epilepsia using Livewrite Premium

Critical Review

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must not exceed 300 words. Abstract must be unstructured.
Manuscript Manuscript must not exceed 5,000 words. Manuscript must contain the sections abstract, introduction, methods, results, and conclusions. Manuscript must include 3 to 5 key bullet points summarizing the article and up to 5 keywords or phrases.
References References must not exceed 100. References may be submitted in any style or format if used consistently throughout the manuscript. References may be formatted in any consistent style or format throughout the manuscript.
Figures & Tables Figures must be uploaded as separate files, and tables must be presented together at the end of the main text document or submitted as separate table files rather than embedded in the main text. Figures and tables must have legends, and each table must be complete with a title and footnotes.
Reformat to Epilepsia using Livewrite Premium

Brief Communication (E-Only)

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. The abstract must not exceed 200 words. The abstract must be unstructured.
Manuscript The manuscript must not exceed 1,800 words. The manuscript must include the sections abstract, introduction, methods, results, and conclusions. The manuscript must include up to 5 keywords or phrases and a second short summary of less than 100 words for the Table of Contents.
References The manuscript must not exceed 18 references. References may be submitted in any consistent style or format.
Figures & Tables The manuscript must include no more than 2 figures and tables combined. Figures must be uploaded as separate files, and tables must be presented together at the end of the main text document or as separate table files rather than embedded in the main text file. Figures and tables must have legends and be cited in the text in numerical order.
Reformat to Epilepsia using Livewrite Premium

Letter

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is not required for Letters.
Manuscript Letters must not exceed 500 words. Letters must include up to 5 keywords or phrases, a conflict of interest disclosure, the Epilepsia ethical publication statement, and the statement that the views expressed are solely those of the authors and do not necessarily reflect the official position of Epilepsia or the International League Against Epilepsy.
References References may be submitted in any style or format if used consistently throughout the manuscript.
Figures & Tables Figures or tables in Letters will be considered only exceptionally. Figures must be uploaded as separate files, and tables must be presented together at the end of the main text document or as separate table files rather than embedded in the main text file. Figures and tables must have legends and must be cited in the text and numbered in the order in which they appear.
Reformat to Epilepsia using Livewrite Premium

Recent Publications

Change in clobazam pharmacokinetics after introduction of cenobamate

Melissa R. Osborn, Kevin F. Haas, Bassel W. Abou‐Khalil

10.1002/epi.70437
View Publication

Impact of sedation on the reliability of magnetoencephalographic language mapping in pediatric epilepsy

Tao Song, Ryan R. Song, Carla Bodden, Rosario Deleon, Joe Cordova, Mingxiong Huang, Clifford Calley

10.1002/epi.70546
View Publication

Beyond seizure control: Non–seizure‐related outcomes in focal‐onset epilepsy treated with adjunctive cenobamate. Third interim results from the BLESS study

Simona Lattanzi, Giuseppe d'Orsi, Maria Teresa Di Claudio, Alfredo D'Aniello, Stefano Luca Sensi, Fedele Dono, Mariangela Panebianco, Luigi Sicurella, Alessandra Di Liberto, Andrea Novara, Carlo Di Bonaventura, Paolo Bonanni, Claudio Liguori, Federica Ranzato, Antonio Gambardella, Francesca Bisulli, Patrizia Pulitano, Giada Pauletto, Elena Tartara, Giampaolo Vatti, Giovanni Assenza, Alfonso Giordano, Anna Elisabetta Vaudano, Gionathan Mazza, Angela La Neve, Pietro Pignatta, Simone Beretta, Marianna Pezzella, Michela Cecconi, Chiara Pizzanelli, Vincenzo Andreone, Catello Vollono, Monica Puligheddu, Massimo Gangitano, Daniela Audenino, Nicoletta Foschi, Elisa Fallica, Giovanni Boero, David Stokelj, Maria Pia Pasolini, Luciana Tramacere, Gionata Strigaro, Edoardo Ferlazzo, Tiziano Zanoni, Pietro Penza, Maurizio Elia, Stefano Quadri, Giovanni De Maria, Monica Santo Sabato, Loretta Giuliano, Rosita Galli, Angelo Labate, Filippo Dainese, Giovanni Falcicchio, Roberto De Simone, Michela Procaccini, Valentina Villano, Gabriele Camattari, Daniele Andreis, Lucia Simoni, Giancarlo Di Gennaro

10.1002/epi.70501
View Publication

Fenfluramine treatment and seizure‐free days in pediatric and adult patients with Lennox–Gastaut syndrome: A post hoc analysis

Stéphane Auvin, Ingrid E. Scheffer, Antonio Gil‐Nagel, Patrick Healy, Amélie Lothe, Mélanie Langlois, Jayne Abraham, Lieven Lagae, Kelly G. Knupp

10.1002/epi.70536
View Publication

Limited sex‐specific structural alterations across common epilepsies: A worldwide ENIGMA study

Huantao Wen, Bin Wan, Taha Gholipour, Ke Xie, Judy Chen, Bianca Serio, Meike D. Hettwer, Marina K. M. Alvim, Donatello Arienzo, Rafael Batista João, Tobias Bauer, Andrea Bernasconi, Neda Bernasconi, Paolo Bonanni, Maria Eugenia Caligiuri, Fernando Cendes, Raphaël Christin, Luis Concha, Arielle Dascal, Edward Davoodi Boyd, Orrin Devinsky, Niels K. N. Focke, Francesco Fortunato, Marian Galovic, Antonio Gambardella, Renzo Guerrini, Sean N. Hatton, Mirana Iliza, Sara Inati, Victoria Ives‐Deliperi, Robert‐Paul Juster, Jonathan K. Kleen, Mohamad Z. Koubeissi, Angelo Labate, Sara Larivière, Meng Law, Matteo Lenge, Stefano Meletti, Patrick B. Moloney, Marlo Naish, Alexander Ngo, Terence J. O'Brien, Raluca Pana, Sofia Panzeri, Heath Pardoe, Erik H. U. Rauf, Antonella Riva, Raúl Rodríguez‐Cruces, Jessica Royer, Theodor Rüber, Ella Sahlas, Lucas Scárdua‐Silva, Kai Michael Schubert, Leigh N. Sepeta, Mariasavina Severino, Benjamin Sinclair, Hamid Soltanian‐Zadeh, Travis Stoub, Pasquale Striano, Sophia I. Thomopoulos, Nina V. Valientes, Anna Elisabetta Vaudano, Lucy Vivash, Clarissa L. Yasuda, Paul M. Thompson, Sanjay M. Sisodiya, Carrie R. McDonald, Boris C. Bernhardt, Sofie L. Valk

10.1002/epi.70515
View Publication

Frequently asked questions

How long does it take to publish?

Median 13 days from submission to first decision, 101 days from submission to acceptance, and 20 days from acceptance to publication.

Reformat to Epilepsia using Livewrite Premium

Is a cover letter required?

A cover letter is expected if a manuscript exceeds the journal's word-limit guidelines, explaining why the additional length is necessary.

Reformat to Epilepsia using Livewrite Premium

What are the publication costs?

Open access publication is available in this hybrid journal. An article publication charge (APC) applies and may be covered by an institution or funder.

Reformat to Epilepsia using Livewrite Premium

Research Topics

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research EEG and Brain-Computer Interfaces Metabolism and Genetic Disorders Neurological disorders and treatments Psychosomatic Disorders and Their Treatments Functional Brain Connectivity Studies Neonatal and fetal brain pathology Diet and metabolism studies Ion channel regulation and function Genetics and Neurodevelopmental Disorders Glycogen Storage Diseases and Myoclonus Drug Transport and Resistance Mechanisms Glioma Diagnosis and Treatment Genomics and Rare Diseases Cerebrospinal fluid and hydrocephalus Advanced MRI Techniques and Applications Sleep and Wakefulness Research Botanical Research and Chemistry Pharmaceutical studies and practices Neural dynamics and brain function Diverse Scientific and Economic Studies Fetal and Pediatric Neurological Disorders Infectious Encephalopathies and Encephalitis

Related Journals

Bi
BioFactors WILEY
JO
Journal of Neural Transmission Springer Science+Business Media
DT
Dental Traumatology WILEY
AN
Advanced NanoBiomed Research WILEY
JO
Journal of Neurology Neurosurgery & Psychiatry BMJ
EM
Emergency Medicine International WILEY